JP2024539088A5 - - Google Patents

Info

Publication number
JP2024539088A5
JP2024539088A5 JP2024523401A JP2024523401A JP2024539088A5 JP 2024539088 A5 JP2024539088 A5 JP 2024539088A5 JP 2024523401 A JP2024523401 A JP 2024523401A JP 2024523401 A JP2024523401 A JP 2024523401A JP 2024539088 A5 JP2024539088 A5 JP 2024539088A5
Authority
JP
Japan
Prior art keywords
cells
cell population
percent
tcr
population
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024523401A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024539088A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/046745 external-priority patent/WO2023069322A1/en
Publication of JP2024539088A publication Critical patent/JP2024539088A/ja
Publication of JP2024539088A5 publication Critical patent/JP2024539088A5/ja
Pending legal-status Critical Current

Links

JP2024523401A 2021-10-20 2022-10-14 腫瘍浸潤ガンマ-デルタt細胞を拡大するための方法及び材料 Pending JP2024539088A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163257805P 2021-10-20 2021-10-20
US63/257,805 2021-10-20
PCT/US2022/046745 WO2023069322A1 (en) 2021-10-20 2022-10-14 Methods and materials for expanding tumor infiltrating gamma-delta t cells

Publications (2)

Publication Number Publication Date
JP2024539088A JP2024539088A (ja) 2024-10-28
JP2024539088A5 true JP2024539088A5 (cg-RX-API-DMAC7.html) 2025-10-09

Family

ID=85980818

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024523401A Pending JP2024539088A (ja) 2021-10-20 2022-10-14 腫瘍浸潤ガンマ-デルタt細胞を拡大するための方法及び材料

Country Status (5)

Country Link
US (1) US20230117388A1 (cg-RX-API-DMAC7.html)
EP (1) EP4419118A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024539088A (cg-RX-API-DMAC7.html)
CA (1) CA3235971A1 (cg-RX-API-DMAC7.html)
WO (1) WO2023069322A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025082502A1 (en) * 2023-10-18 2025-04-24 Nanjing Legend Biotech Co., Ltd. Pan t cells and methods of manufacturing of the same
ES3034332B2 (es) * 2025-05-21 2026-05-08 Univ Madrid Complutense Método de expansión selectiva in vitro y adquisición de fenotipo residente en tejido decélulas T Yo Vo1+ derivadas de sangre periférica

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2336302T3 (es) * 2000-04-03 2010-04-12 Therapure Biopharma Inc. Produccion de celulas ttcr gamma delta.
US9907820B2 (en) * 2013-10-25 2018-03-06 Board Of Regents, The University Of Texas System Polyclonal gamma delta T cells for immunotherapy
GB201506423D0 (en) * 2015-04-15 2015-05-27 Tc Biopharm Ltd Gamma delta T cells and uses thereof
RU2756247C2 (ru) * 2014-11-17 2021-09-28 Эдисет Био, Инк. Генетически модифицированные гамма дельта т-клетки
CN118421557A (zh) * 2016-05-12 2024-08-02 阿迪塞特治疗公司 选择性扩增γδT细胞群的方法及其组合物
GB201707048D0 (en) * 2017-05-03 2017-06-14 King S College London Expansion of gamma delta cells, compositions, and methods of use thereof
WO2018229163A1 (en) * 2017-06-14 2018-12-20 King's College London Methods of activating v delta 2 negative gamma delta t cells
CA3082818A1 (en) * 2017-11-15 2019-05-23 Adicet Bio Inc. Methods for selective expansion of .delta.3 .gamma..delta. t-cell populations and compositions thereof
EP3927353A4 (en) * 2019-02-24 2022-11-23 Gamida-Cell Ltd. METHOD OF ECOTAXY AND RETENTION OF GAMMADELTA T LYMPHOCYTES, OPTIONALLY WITH NATURAL KILLER CELLS, ALLOWING THE GENERATION OF CELLULAR COMPOSITIONS FOR USE IN THERAPY
CA3148588A1 (en) * 2019-08-16 2021-02-25 GammaDelta Therapeutics Limited Ex vivo gamma delta t cell populations

Similar Documents

Publication Publication Date Title
JP2020518289A5 (cg-RX-API-DMAC7.html)
Consentius et al. Immunogenicity of allogeneic mesenchymal stromal cells: what has been seen in vitro and in vivo?
DE102017127984B4 (de) Verfahren für die Vermehrung und Aktivierung von γδ-T-Zellen
Bozzano et al. Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity
Turka et al. Thymocyte expression of RAG-1 and RAG-2: termination by T cell receptor cross-linking
Chen et al. Analysis of allogenicity of mesenchymal stem cells in engraftment and wound healing in mice
Wei et al. Functional tooth restoration by allogeneic mesenchymal stem cell-based bio-root regeneration in swine
Chamley et al. Comparison of vascular smooth muscle cells from adult human, monkey and rabbit in primary culture and in subculture
Gielen et al. Progressive replacement of human cultured epithelial allografts by recipient cells as evidenced by HLA class I antigens expression
Liu et al. CD44 expression positively correlates with Foxp3 expression and suppressive function of CD4+ Treg cells
Merola et al. Progenitor-derived human endothelial cells evade alloimmunity by CRISPR/Cas9-mediated complete ablation of MHC expression
SHER et al. Acceptance of allogeneic fibroblasts in skin equivalent transplants
Mendt et al. Metabolic reprogramming of GMP grade cord tissue derived mesenchymal stem cells enhances their suppressive potential in GVHD
Yang et al. Amelioration of acute graft‐versus‐host disease by adoptive transfer of ex vivo expanded human cord blood CD4+ CD25+ forkhead box protein 3+ regulatory T cells is associated with the polarization of Treg/Th17 balance in a mouse model
Naha Temperature sensitive conditional mutants of monkey kidney cells
Moretta et al. Assignment of human natural killer (NK)‐like cells to the T cell lineage. Single allospecific T cell clones lyse specific or NK‐sensitive target cells via distinct recognition structures
US8076134B2 (en) CD4+CD25− T cells and Tr1-like regulatory T cells
Jewett et al. Tumor microenvironment may shape the function and phenotype of NK cells through the induction of split anergy and generation of regulatory NK cells
Cohen et al. Rejection of tumor allografts by mouse spleen cells sensitized in vitro
Jeon et al. The immunomodulatory effect of adipose-derived stem cells in xenograft transplantation model
JP2023514788A5 (cg-RX-API-DMAC7.html)
Johnson et al. Natural killer cells in skin: a unique opportunity to better characterize the many facets of an overlooked secondary lymphoid organ
Rygaard SKIN GRAFTS IN NUDE MICE: 2. Rat Skin Grafts in Nude Mice of Three Genetic Backgrounds (BALB/c, C3H, C57/BL). The Effects after Preparation by Thymus Grafts
Pastille et al. Exploring the role of innate lymphoid cells in the periodontium: insights into immunological dynamics during orthodontic tooth movement
US20200095549A1 (en) Method for inducing regulatory t cell